Depressive symptomatology in men receiving androgen deprivation therapy for prostate cancer: a controlled comparison

Abstract

Findings support the hypothesis that ADT administration yields increases in depression and suggest that the mechanism behind ADT's association with depression should be explored and that prostate cancer patients treated with ADT should receive particular focus in depression screening and intervention.